N. Shibata

H. Arai, N. Shibata, T. Ohnuma, 2015, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

No association between glutathione‐synthesis‐related genes and Japanese schizophrenia

H. Baba, H. Arai, N. Shibata, 2011, Psychiatry and clinical neurosciences.

Haloperidol plasma concentration in Japanese psychiatric subjects with gene duplication of CYP2D6.

H. Arai, N. Shibata, T. Ohnuma, 2003, British journal of clinical pharmacology.

Safety and tolerability of immune globulin intravenous (human), 10% solution in Japanese subjects with mild to moderate Alzheimer's disease

T. Tokuda, H. Arai, N. Shibata, 2014, Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society.

Genetic Association between Ghrelin Polymorphisms and Alzheimer’s Disease in a Japanese Population

H. Arai, N. Shibata, T. Ohnuma, 2011, Dementia and Geriatric Cognitive Disorders.

Genetic association between APOA1 and APOD polymorphisms and Alzheimer’s disease in a Japanese population

Shunichiro Shinagawa, Hisashi Yamada, H. Arai, 2013, Journal of Neural Transmission.

Association studies between the plasmin genes and late-onset Alzheimer's disease

Y. Meng, R. Mayeux, L. Farrer, 2007, Neurobiology of Aging.

No genetic association between alpha-2 macroglobulin I1000V polymorphism and Japanese sporadic Alzheimer's disease

H. Arai, A. Ueki, N. Shibata, 2000, Neuroscience Letters.

No genetic association between SLC7A10 and Japanese patients with schizophrenia

H. Baba, H. Arai, N. Shibata, 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Hyperostosis frontalis interna in a patient with Alzheimer's disease

N. Shibata, T. Koinuma, Narihiro Orimo, 2022, Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society.

Association between Physical Restraint and Drug-Induced Liver Injury

H. Arai, N. Shibata, C. Usui, 2008, Neuropsychobiology.

Association between DNA Methylation of the BDNF Promoter Region and Clinical Presentation in Alzheimer's Disease

Hisashi Yamada, Kazuhiro Kondo, Tohru Ohnuma, 2015, Dementia and Geriatric Cognitive Disorders Extra.

Meta-analysis of the Association Between Variants in SORL 1 and Alzheimer Disease

J. Haines, M. Pericak-Vance, M. Owen, 2011 .

Erratum to: Genetic Association Between KIBRA Polymorphism and Alzheimer’s Disease with in a Japanese Population

K. Tagai, Shunichiro Shinagawa, Hisashi Yamada, 2015, NeuroMolecular Medicine.

A genome-wide association study of late-onset Alzheimer’s disease in a Japanese population

Takashi Morihara, Masatoshi Takeda, Shigenobu Kanba, 2015, Psychiatric genetics.

Genetic association between Notch4 polymorphisms and Alzheimer's disease in the Japanese population.

Tomoko Watanabe, H. Arai, A. Ueki, 2007, The journals of gerontology. Series A, Biological sciences and medical sciences.

Genetic Association Between KIBRA Polymorphism and Alzheimer’s Disease with in a Japanese Population

Shunichiro Shinagawa, Hisashi Yamada, H. Arai, 2015, NeuroMolecular Medicine.

Genetic association between CALHM1, 2, and 3 polymorphisms and Alzheimer's disease in a Japanese population.

H. Baba, H. Arai, N. Shibata, 2010, Journal of Alzheimer's disease : JAD.

Association of copy number polymorphisms at the promoter and translated region of COMT with Japanese patients with schizophrenia

M. Ikeda, R. Hashimoto, H. Yamamori, 2016, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Significance of measurements of peripheral carbonyl stress markers in a cross-sectional and longitudinal study in patients with acute-stage schizophrenia.

H. Arai, N. Shibata, T. Ohnuma, 2014, Schizophrenia bulletin.

Plasma Concentration of Risperidone Showed a Correlation with Daily Dose, but not with Age nor Cytochrome P‐450 2D6 Gene Polymorphisms in Japanese Schizophrenics

H. Arai, N. Shibata, Tadashi C. Takahashi, 2002 .

Effect of IL-6 polymorphism on risk of Alzheimer disease: genotype-phenotype association study in Japanese cases.

H. Baba, H. Arai, A. Ueki, 2002, American journal of medical genetics.

Clinical Interventions in Aging Dovepress

H. Arai, N. Shibata, T. Ota, 2022 .

Genetic association between USF 1 and USF 2 gene polymorphisms and Japanese Alzheimer's disease.

Tomoko Watanabe, H. Arai, A. Ueki, 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.

No genetic association between the SLC1A2 gene and Japanese patients with schizophrenia

H. Baba, H. Arai, N. Shibata, 2009, Neuroscience Letters.

Genetic analysis of the TrkB gene and schizophrenia in the Japanese population: Juntendo University Schizophrenia Projects (JUSP)

H. Arai, N. Shibata, T. Ohnuma, 2007, Neuroscience Letters.

Association study between Disrupted-in-Schizophrenia-1 (DISC1) and Japanese patients with treatment-resistant schizophrenia (TRS)

H. Baba, H. Arai, Toshihito Suzuki, 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

The Relationship Between the Response of Clinical Symptoms and Plasma Olanzapine Concentration, Based on Pharmacogenetics: Juntendo University Schizophrenia Projects (JUSP)

H. Arai, N. Shibata, T. Ohnuma, 2008, Therapeutic drug monitoring.

Genetic evidence for association between NOTCH4 and schizophrenia supported by a GWAS follow-up study in a Japanese population

E. Hattori, M. Ikeda, T. Toyota, 2013, Molecular Psychiatry.

No genetic association between polymorphisms in the Fyn kinase gene and age of schizophrenic onset

H. Arai, N. Shibata, M. Yamashina, 2003, Neuroscience Letters.

Altered serum glyceraldehyde-derived advanced glycation end product (AGE) and soluble AGE receptor levels indicate carbonyl stress in patients with schizophrenia

Yusuke Suzuki, Y. Tomino, H. Arai, 2015, Neuroscience Letters.

No associations found between the genes situated at 6p22.1, HIST1H2BJ, PRSS16, and PGBD1 in Japanese patients diagnosed with schizophrenia

M. Ikeda, K. Ohi, R. Hashimoto, 2012, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Medium‐chain triglycerides given in the early stage of mild‐to‐moderate Alzheimer's disease enhance memory function

H. Arai, N. Shibata, T. Ota, 2017, Psychogeriatrics.

Genetic association between RAGE polymorphisms and Alzheimer's disease and Lewy body dementias in a Japanese cohort: a case–control study

N. Hattori, Shunichiro Shinagawa, Hisashi Yamada, 2017, International journal of geriatric psychiatry.

Association analysis between functional polymorphism of the rs4606 SNP in the RGS2 gene and antipsychotic-induced Parkinsonism in Japanese patients with schizophrenia: Results from the Juntendo University Schizophrenia Projects (JUSP)

H. Arai, Toshihito Suzuki, N. Shibata, 2010, Neuroscience Letters.

Safety and pharmacokinetics of bapineuzumab in a single ascending‐dose study in Japanese patients with mild to moderate Alzheimer's disease

E. Kirino, H. Baba, H. Arai, 2016, Geriatrics & gerontology international.

Usefulness of DNA Methylation Levels in COASY and SPINT1 Gene Promoter Regions as Biomarkers in Diagnosis of Alzheimer’s Disease and Amnestic Mild Cognitive Impairment

Shunichiro Shinagawa, Hisashi Yamada, H. Arai, 2016, PloS one.

Development of Biomarkers Based on DNA Methylation in the NCAPH2/LMF2 Promoter Region for Diagnosis of Alzheimer’s Disease and Amnesic Mild Cognitive Impairment

Shunichiro Shinagawa, Hisashi Yamada, H. Arai, 2016, PloS one.

Genetic Association Between CALHM1, 2 and 3 Polymorphisms and Alzheimer’s Disease in a Japanese Population

H. Baba, H. Arai, N. Shibata, 2011, Alzheimer's & Dementia.

Comparison of Causes of Loneliness and Coping Behaviors Among Japanese and Chinese University Student Samples

Akari Kamimura, N. Shibata, Y. Kawata, 2021 .

Successful Treatment of Inappropriate Sexual Behavior and Disinhibition in Dementia With Paroxetine.

N. Shibata, Y. Nagai, 2023, Journal of clinical psychopharmacology.

No Correlation between Plasma NMDA-Related Glutamatergic Amino Acid Levels and Cognitive Function in Medicated Patients with Schizophrenia

H. Arai, N. Shibata, T. Ohnuma, 2012, International journal of psychiatry in medicine.

No association between a 3’ untranslated region polymorphism in the neprilysin gene and Alzheimer's disease in the Japanese population

H. Arai, A. Ueki, N. Shibata, 2005 .

Genetic Association between PLTP Gene Polymorphisms and Alzheimer’s Disease in a Japanese Population

H. Arai, N. Shibata, T. Ohnuma, 2010, Dementia and Geriatric Cognitive Disorders.

Development of the Athletic Vulnerability Scale: An Examination of Vulnerability Among University Athletes and Related Factors

Masataka Hirosawa, N. Shibata, Miyuki Nakamura, 2019, Juntendo Medical Journal.

Differential effects of acute exercise on emotional memory in men and women

Masataka Hirosawa, N. Shibata, T. Ota, 2023, Frontiers in Sports and Active Living.

Genetic Association between Neurotrophin-3 Polymorphisms and Alzheimer's Disease in Japanese Patients

Shunichiro Shinagawa, Hisashi Yamada, H. Arai, 2013, Dementia and Geriatric Cognitive Disorders Extra.

High serum soluble tumor necrosis factor receptor 1 predicts poor treatment response in acute-stage schizophrenia

Yusuke Suzuki, Y. Tomino, H. Arai, 2017, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Lack of Genetic Association of the UCHL1 Gene with Alzheimer’s Disease and Parkinson’s Disease with Dementia

N. Hattori, H. Arai, Y. Motoi, 2012, Dementia and Geriatric Cognitive Disorders.

Impact of anti-doping education and doping control experience on anti-doping knowledge in Japanese university athletes: a cross-sectional study

Akari Kamimura, Masataka Hirosawa, N. Shibata, 2018, Substance Abuse Treatment, Prevention, and Policy.

No genetic association between Fyn kinase gene polymorphisms (−93A/G, IVS10+37T/C and Ex12+894T/G) and Japanese sporadic Alzheimer's disease

Tomoko Watanabe, H. Arai, A. Ueki, 2004, Neuroscience Letters.

Serum insulin‐like growth factor‐I and amyloid beta protein in Alzheimer's disease: relationship with cognitive function

H. Arai, N. Shibata, Y. Ichimiya, 2016, Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society.

High doses of antipsychotic polypharmacy are related to an increase in serum levels of pentosidine in patients with schizophrenia

Yusuke Suzuki, Y. Tomino, H. Arai, 2017, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

No genetic association between PCSK9 polymorphisms and Alzheimer's disease and plasma cholesterol level in Japanese patients.

Tomoko Watanabe, H. Arai, A. Ueki, 2005, Psychiatric genetics.

The effect of IL4 +33C/T polymorphism on risk of Japanese sporadic Alzheimer's disease

H. Baba, H. Arai, A. Ueki, 2002, Neuroscience Letters.

Changes in plasma glycine, l-serine, and d-serine levels in patients with schizophrenia as their clinical symptoms improve: Results from the Juntendo University Schizophrenia Projects (JUSP)

H. Arai, Toshihito Suzuki, N. Shibata, 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

No Associations Found between PGBD1 and the Age of Onset in Japanese Patients Diagnosed with Sporadic Alzheimer's Disease

H. Arai, N. Shibata, T. Ohnuma, 2012, Dementia and Geriatric Cognitive Disorders Extra.

Understanding dementia for dentists

H. Arai, N. Shibata, 2014 .

No genetic association between tryptophan hydroxylase 2 gene polymorphisms and Japanese schizophrenia.

H. Arai, N. Shibata, T. Ohnuma, 2007, Psychiatric genetics.

Increased plasma glutamate by antipsychotic medication and its relationship to glutaminase 1 and 2 genotypes in schizophrenia — Juntendo University Schizophrenia Projects (JUSP)

H. Baba, H. Arai, Toshihito Suzuki, 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Polymorphisms in the aldehyde dehydrogenase 2 and dopamine β hydroxylase genes are not associated with Alzheimer’s disease

H. Arai, N. Shibata, T. Ohnuma, 2014, Journal of Neural Transmission.

No genetic association between postsynaptic density-95 gene polymorphisms and schizophrenia

H. Arai, N. Shibata, T. Ohnuma, 2006, Neuroscience Letters.

Genetic Association between Akt1 Polymorphisms and Alzheimer's Disease in a Japanese Population

H. Baba, H. Arai, N. Shibata, 2011, International journal of Alzheimer's disease.

Genetic association between cytochrome P-450 2d6 gene polymorphism and plasma concentration of haloperidolin Japanese schizophrenics

H. Baba, H. Arai, N. Shibata, 1999 .

Genetic association between cytochrome P-450 2D6 gene polymorphism and plasma concentration of haloperidol in Japanese schizophrenics.

H. Baba, N. Shibata, H. Shimada, 1999, Psychiatric genetics.

The Impact of Physical Activity Enjoyment on Motor Ability

Akari Kamimura, Masataka Hirosawa, N. Shibata, 2018, Advances in Intelligent Systems and Computing.

Psychiatric and psychological outcomes of Japanese living donors following liver transplantation

S. Kawasaki, H. Arai, N. Shibata, 2009, Psychiatry and clinical neurosciences.

Genetic Association between Presenilin 2 Polymorphisms and Alzheimer's Disease and Dementia of Lewy Body Type in a Japanese Population

N. Hattori, Shunichiro Shinagawa, Hisashi Yamada, 2016, Dementia and Geriatric Cognitive Disorders Extra.

Genetic association between RAGE polymorphisms and Alzheimer's disease and Lewy body dementia with in a Japanese population

Shunichiro Shinagawa, H. Arai, K. Nakayama, 2018 .

Genetic association between clusterin polymorphisms and Alzheimer's disease in a Japanese population

H. Baba, H. Arai, N. Shibata, 2011, Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society.

Meta-analysis of the association between SORL1 variants and Alzheimer's disease

M. Pericak-Vance, M. Owen, W. Maier, 2010, Alzheimer's & Dementia.

The Relationship Between the Response of Clinical Symptoms and Plasma Olanzapine Concentration, Based on Pharmacogenetics: Juntendo University Schizophrenia Projects (JUSP)

H. Arai, N. Shibata, T. Ohnuma, 2008, Therapeutic drug monitoring.

Benefits of use, and tolerance of, medium-chain triglyceride medical food in the management of Japanese patients with Alzheimer’s disease: a prospective, open-label pilot study

H. Arai, N. Shibata, T. Ota, 2016, Clinical interventions in aging.

Changes in Mini‐Mental State Examination score in Alzheimer's disease patients after stopping habitual drinking

H. Arai, N. Shibata, Aiko Toda, 2013, Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society.

Associations of common copy number variants in glutathione S‐transferase mu 1 and D‐dopachrome tautomerase‐like protein genes with risk of schizophrenia in a Japanese population

H. Arai, N. Shibata, T. Ohnuma, 2015, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Low‐dose lamotrigine augmentation therapy improves residual symptoms in treatment‐resistant schizophrenia: A report of five cases

H. Arai, N. Shibata, T. Ohnuma, 2013, Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists.